subject area of
- Activation and Active Site Occupation Alter Conformation in the Region of the First Epidermal Growth Factor-like Domain of Human Factor VII Journal Articles
- Age‐related changes in factor VII proteolysis in vivo Journal Articles
- An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency Journal Articles
- Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age? Journal Articles
- Changes in coagulation factor activity and content of di(2‐ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing Journal Articles
- Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy Journal Articles
- Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers Journal Articles
- Complete nucleotide sequence of the cdna encoding rabbit coagulation factor VII Journal Articles
- Continuous Infusion of Recombinant Factor VIIa in Hemophilic Patients with Inhibitors: Safety, Monitoring, and Cost Effectiveness Journal Articles
- Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium Journal Articles
- Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers Journal Articles
- Factor VII Deficiency Caused by a Structural Variant N57D of the First Epidermal Growth Factor Domain Journal Articles
- Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene Journal Articles
- Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding Journal Articles
- Frequent association of factor VII defects with other clotting disorders Journal Articles
- Glycosaminoglycans Bind Factor Xa in a Ca2+-Dependent Fashion and Modulate Its Catalytic Activity Journal Articles
- Haemostatic and replacement therapy in von Willebrand disease Journal Articles
- Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography Journal Articles
- Hemophilia in the 1990s: Principles of Management and Improved Access to Care Journal Articles
- Hemostasis and atherosclerosis. Journal Articles
- Hemostatic System Activation in Patients with Lupus Anticoagulant and Essential Thrombocythemia Journal Articles
- Hypercoagulability. Journal Articles
- Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus Journal Articles
- Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients Journal Articles
- LETTERS TO THE EDITOR Journal Articles
- Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z Journal Articles
- Metabolism of rabbit plasma-derived factor VII in relation to prothrombin in rabbits Journal Articles
- New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management Conferences
- Optimal reversal of vitamin K antagonists Journal Articles
- Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn Journal Articles
- Plasma factor VII and thrombin–antithrombin III levels indicate increased tissue factor activity in sickle cell patients Journal Articles
- Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery Journal Articles
- Prolonged hemorrhagic shock does not impair regeneration of plasma coagulant masses in the rabbit Journal Articles
- Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent Journal Articles
- Recombinant FVIIa in children with liver disease Journal Articles
- Recombinant activated factor VII for the treatment of life-threatening haemorrhage Journal Articles
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY Journal Articles
- Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw Journal Articles
- Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose Journal Articles
- Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves Journal Articles
- The Influence of Helicobacter pylori Status on Circulating Levels of the Coagulation Factors Fibrinogen, von Willebrand Factor, Factor VII, and Factor VIII Journal Articles
- The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Journal Articles
- The direct binding of human factor VII in plasma to recombinant human tissue factor Journal Articles
- The factor VIII-independent activation of factor X by factors IXa and VII in plasma Journal Articles
- The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor Journal Articles
- The immunodepletion of factor VII from human plasma using a monoclonal antibody Journal Articles
- The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery Journal Articles
- The onerous task of comparing treatments in inhibitor patients Journal Articles
- Thrombotic Complications after Substitution with a FVII Concentrate Journal Articles
- Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia Journal Articles
- Variability of clinical manifestation of factor VII-deficiency in homozygous and heterozygous subjects of the European F7 gene mutation A294V Journal Articles
- [Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative]. Journal Articles